U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...In 1790, the cost to obtain a patent was between $4 and $5.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 546/14 - Silicon containing


Subclass of Class 546 - Organic compounds -- part of the class 532-570 series
Definition: Compounds which contain silicon.
No. of applications: 200
Last issue date: 05/03/2012


1          
Application No.Application TitleIssue Date
20120107328GAMMA SECRETASE MODULATORS
This invention provides novel compounds that are modulators of gamma secretase. The compounds have the formula (I). Also disclosed are methods of modulating gamma secretase activity and methods of treating Alzheimer's Disease using the compounds of formula (I).

05/03/2012
20120070781BASE GENERATOR, PHOTOSENSITIVE RESIN COMPOSITION, PATTERN FORMING MATERIAL COMPRISING THE PHOTOSENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD USING THE PHOTOSENSITIVE RESIN COMPOSITION AND PRODUCTS COMPRISING THE SAME
An object of the present invention is to provide a base generator which has sensitivity and is applicable to a wide range of applications, and a photosensitive resin composition which is applicable to a wide range of applications due to the structure of a polymer precur... 		03/22/2012
20120053310Aminosilane Compounds, Catalyst Components and Catalysts for Olefin Polymerization, and Process for Production of Olefin Polymers with the Same
A catalyst for polymerization of olefins formed from (A) a solid catalyst component containing magnesium, titanium, halogen, and an electron donor compound, (B) an organoaluminum compound shown by the formula, R6pAlQ3-p, and (C) an amino... 		03/01/2012
20120053202POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
Compounds of formula (I):

wherein R1, R2, R3, R4, Het and X are as defined in the disclosure, or an acid addition salt thereof, and the therapeutic use and process ...

03/01/2012
20120053146PESTICIDAL COMPOSITIONS
Molecules according to Formula One:

and their uses are disclosed herein....

03/01/2012
20120029192Pyrazole Derivatives
This invention relates to pyrazole derivatives of formula (I)

or pharmaceutically acceptable salts, solvates or derivatives thereof, and to processes for the preparation thereof, intermediates used in their p...

02/02/2012
20120022258Novel Processes for the manufacture of Propane-1-sulfonic acid -amide
According to the present invention there are provided novel processes for the manufacture of the compound of formula 1

as well as intermediates and novel synthesis routes for key intermediates used in those p...

01/26/2012
20120012821SILYL- AND HETEROATOM-SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZOPHOSPHOLES, AND USE THEREOF IN ORGANIC ELECTRONICS
The present invention relates to silyl- and heteroatom-substituted compounds selected from carbazoles, dibenzofurans, dibenzothiophenes and disilylbenzophospholes of the formula (I) or (I*), to the use of the compounds of the formula (I) or (I*) in organic electronics a... 		01/19/2012
20120016128Rhodamine lactone phosphoramidites and polymers
The present invention provides rhodamine lactone phosphoramidites and polymer compositions, methods for making these phosphoramidites and polymer compositions, and methods for using these phosphoramidites and polymer compositions for labeling oligonucleotides. In partic... 		01/19/2012
20120010402CGRP Receptor Antagonists
The disclosure generally relates to the novel compounds of formula I, including their salts, which are CGRP receptor antagonists. The disclosure also relates to pharmaceutical compositions and methods for using the compounds in the treatment of CGRP related disorders in... 		01/12/2012
20120004196Anti-Viral Compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.... 		01/05/2012
20110318266PHTHALIMIDE DERIVATIVE METABOTROPIC GLUTAMATE R4 LIGANDS
Disclosed are mGluR4 positive allosteric modulator ligands of general formula (I) and radiolabeled derivates, their use as therapeutic agents for the treatment of central nervous system disorders modulated by mGluR4 and as ligands for the labeling and diagnostic imaging... 		12/29/2011
20110311601ANTIMICROBIAL MEDICAL DEVICES
A medical device having a silane surface comprising an antimicrobial peptide exhibiting a complex tertiary structure, wherein the antimicrobial peptide is attached to the silane surface via reversible interaction.... 		12/22/2011
20110301122HETEROAROMATIC COMPOUNDS FOR USE AS HIF INHIBITORS
The present application relates to novel substituted aryl compounds, processes for their preparation, their use for treatment and/or prevention of diseases and their use for the preparation of medicaments for treatment and/or prevention of diseases, in particular for tr... 		12/08/2011
20110293852ORGANOMETALLIC PRECURSOR COMPOUNDS
This invention relates to organometallic precursor compounds represented by the formula (H)mM(R)n wherein M is a metal or metalloid, R is the same or different and is a substituted or unsubstituted, saturated or unsaturated, heterocyclic radical co... 		12/01/2011
20110287369RESIST UNDERLAYER FILM FORMING COMPOSITION CONTAINING SILICON HAVING ANION GROUP
There is provided a resist underlayer film forming composition for lithography for forming a resist underlayer film capable of being used as a hardmask. A resist underlayer film forming composition for lithography comprising a silane compound containing an anion group, ... 		11/24/2011
20110287408Preparation of Micro-Porous Crystals and Conjugates Thereof
A conjugate comprising a dye-labeled microporous crystal, a stop-cock moiety, and covalently bound thereto an affinity binding agent is disclosed. The dye-labeled microporous crystal is a zeolite crystal, such as a zeolite L crystal, having a large number of channels in... 		11/24/2011
20110288051TRIAZOLOPYRIDINE 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenas... 		11/24/2011
20110282060NITRIC OXIDE-RELEASING DIAZENIUMDIOLATED COMPOUNDS
The invention described herein provides for novel nitric oxide-releasing polymers that comprise at least two adjacent units derived from acrylonitrile monomer units and containing at least one carbon-bound diazeniumdiolate. The diazeniumdiolated acrylonitrile-derived po... 		11/17/2011
20110281388Cross-Linked Quantum Dots and Methods for Producing and Using the Same
The present invention relates to modified quantum dots (QDs) and methods for using and producing the same. Some aspects of the invention provide cross-linked quantum dots and methods for producing and using the same.... 		11/17/2011
20110275595Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
The present invention relates to compounds defined by formula I wherein the groups R1, Y1 to Y4, V, W, and X are defined as in claim 1, possessing valuable pharmacological activity. Particularly the compounds are inhibitors of 11 ... 		11/10/2011
20110275792METAL COORDINATED COMPOSITIONS
A metal coordination complex of a biologically active moiety and a metal is disclosed. The complex confers to the biologically active moiety an improved performance which can include potency, stability, absorbability, targeted delivery, and combinations thereof.... 		11/10/2011
20110269962PROCESS FOR PREPARING STATINS
Process for the preparation of β-ketoester synthetic intermediates useful in the preparation of statins, in particular Pitavastatin.... 		11/03/2011
20110269712Fungicidal Carboxamides
This invention is directed to compounds of Formula (1) including all geometric and stereoisomers, N oxides, and agriculturally suitable salts thereof, agricultural compositions containing them and their use as fungicides, (1) provided that the compound of Formula 1 is o... 		11/03/2011
20110263529GAMMA SECRETASE MODULATORS
In its many embodiments, the present invention provides a novel class of heterocyclic compounds as modulators of gamma secretase, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical ... 		10/27/2011
20110220881COMPOUND HAVING TRIPHENYLSILYL GROUP AND TRIARYLAMINE STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE
The invention provides a light emitting layer host compound and an electron-blocking compound that have high excited triplet levels, and can completely confine the triplet excitons of phosphorescent material, for use as the material of a high-efficient organic electrolu... 		09/15/2011
20110223134FUSED TRICYCLIC SILYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
The present invention relates to novel Fused Tricyclic Silyl Compounds of Formula (I):

and pharmaceutically acceptable salts thereof, wherein A, B, C, D, M1, X1 and X2 are as ...

09/15/2011
20110206607IMIDAZOL (1,2-A)PYRIDINES AND RELATED COMPOUNDS WITH ACTIVITY AT CANNABINOID CB2 RECEPTORS
Disclosed herein are compounds of Formula (I), or a pharmaceutically acceptable salt, ester, amide, thereof; and methods of modulating the activity of a cannabinoid CB2 receptor comprising contacting a compound of Formula I with the cannabinoid CB2 receptor. Also disclo... 		08/25/2011
20110207698HETEROARYL-SUBSTITUTED DICYANOPYRIDINES AND THEIR USE
The present application relates to novel heteroaryl-substituted dicyanopyridines, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of disease... 		08/25/2011
20110207700TRICYCLIC COMPOUND AND USE THEREOF
The present invention relates to the compound represented by formula (I):

(wherein, all the symbols have the same meaning as that of the specification), a salt thereof, a solvate thereof or a prodrug thereof....

08/25/2011
20110207699Anti-Viral Compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.... 		08/25/2011
20110193064DIAMINOPYRENE DERIVATIVE AND ORGANIC EL DEVICE USING THE SAME
An organic EL device includes an emitting layer provided between an anode and a cathode. The emitting layer contains a diaminopyrene derivative represented by the following formula (1) as an emitting material for the organic EL device. The diaminopyrene derivative emits... 		08/11/2011
20110195929COMPOUNDS FOR THE TREATMENT OF FLAVIVIRAL INFECTIONS
Described are various compounds and methods for the treatment of flaviviral infections. In particular, alkaloids and imino sugars in arabinose and/or lyxose stereochemical configuration with antiflaviviral activity are described.... 		08/11/2011
20110195930PYRIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND PROCESS FOR ITS PRODUCTION
To provide a novel pesticide. The present invention provides a pesticide which contains, as an active ingredient, novel pyridine derivative represented by the formula (I) or its salt: wherein R1 is alkyl, cycloalkyl, alkoxyalkyl or OR3; R2 		08/11/2011
201101839381,7-DIAZACARBAZOLES AND METHODS OF USE
The invention relates to 1,7-diazacarbazole compounds of Formula (I), (I-a) and (I-b) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chk1) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions... 		07/28/2011
20110165346Precursors for CVD Silicon Carbo-Nitride Films
Classes of liquid aminosilanes have been found which allow for the production of silicon carbo-nitride films of the general formula SixCyNz. These aminosilanes, in contrast, to some of the precursors employed heretofore, are liquid at ro... 		07/07/2011
20110143966Surface Modifications and Methods for their Synthesis and Use
Novel processes are disclosed for forming an array of polymers by functionalizing the surface of particles by methods that include covalently attaching a functionalized silicon compound. Substrates such as microparticles having functionalized silicon compounds attached ... 		06/16/2011
20110143967SURFACE MODIFICATIONS AND METHODS FOR THEIR SYNTHESIS AND USE
Novel processes are disclosed for forming an array of polymers by functionalizing the surface of particles by methods that include covalently attaching a functionalized silicon compound. Substrates such as microparticles having functionalized silicon compounds attached ... 		06/16/2011
20110144291Post-Metallocene Complexes Based on Bis(Naphtoxy)Pyridine and Bis(Naphtoxy)Thiophene Ligands for the Polymerisation of Ethylene and Alpha-Olefins
The present invention relates to the field of group 4 post-metallocene complexes based on sterically encumbered bis(naphtoxy)pyridine and bis(naphtoxy)thiophene ligands. It also relates to the use of such post-metallocene complexes in the polymerisation of ethylene and ... 		06/16/2011
20110127513NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME
The present invention provides a novel nitrogen-containing heterocyclic derivative and an organic electronic device using the same. The organic electronic device according to the present invention has excellent properties in terms of efficiency, driving voltage, and a l... 		06/02/2011
1          
 
Sign InRegister
Username  
Password   
forgot password?